Journal
FUTURE ONCOLOGY
Volume 11, Issue 16, Pages 2263-2266Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/fon.15.161
Keywords
HCC; multikinase inhibitors; RAS; RAF; MEK; ERK pathway; sorafenib